Lobbying Expenditures of the Health Sector During the COVID-19 Pandemic

Authors

Adam Olson, University of Cincinnati
John Barrick, Brigham Young University - Provo
William B. Tayler, Brigham Young University - ProvoFollow
Shivaram Rajgopal, Columbia Business School
Ge Bai, Johns Hopkins Bloomberg School of Public Health

Keywords

COVID-19 relief legislation, health sector lobbying, political influence, public policy, healthcare spending, pandemic response

Abstract

As of June 30, 2020, Congress had enacted six bills authorizing approximately $3 trillion in COVID-19 pandemic relief, representing the largest relief package in US history. The bills allocate funds to federal agencies, health care providers, COVID-19 testing, Medicaid funding, stimulus checks, unemployment benefits, and small business assistance, among other purposes.1 Prior research has found that health care organizations spend substantial financial resources on influencing legislative outcomes.2,3 In this study, we examine lobbying efforts of the health sector relative to other sectors before and during the COVID-19 pandemic.

Original Publication Citation

Olson, A., J. Barrick, W. B. Tayler, S. Rajgopal, G. Bai. 2020. Lobbying Expenditures of the Health Sector during the COVID-19 Pandemic. Journal of General Internal Medicine, 35(10): 3133-3136.

BYU ScholarsArchive Citation

Olson, Adam; Barrick, John; Tayler, William B.; Rajgopal, Shivaram; and Bai, Ge, "Lobbying Expenditures of the Health Sector During the COVID-19 Pandemic" (2020). Faculty Publications. 8202.
https://scholarsarchive.byu.edu/facpub/8202

Document Type

Peer-Reviewed Article

Publication Date

2020

Publisher

Journal of General Internal Medicine

Language

English

College

Marriott School of Business

Department

Accountancy

University Standing at Time of Publication

Full Professor

Copyright Use Information

https://lib.byu.edu/about/copyright/